Full Press Release Details
SAN RAFAEL, Calif. , Dec. 18, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) today announced that Jean-Jacques Bienaimé , Chairman and Chief Executive Officer, will participate in the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 8:30 am PT , or 11:30 am ET , in San Francisco, California . To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com . A replay will also be archived on the site for at least one week following the event.
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com . Information on BioMarin's website is not incorporated by reference into this press release.
| Contacts: | |
| Investors | Media |
| Traci McCarty | Debra Charlesworth |
| BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
| (415) 455-7558 | (415) 455-7451 |
SOURCE BioMarin Pharmaceutical Inc.